0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover690.09%IV-71.08%PremiumDec 20, 2024Expiry Date12.29Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9726Delta0.0044Gamma1.38Leverage Ratio-0.0816Theta0.0006Rho1.35Eff Leverage0.0013Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet